Literature DB >> 17182592

Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases.

Alla L Zozulya1, Emily Reinke, Dana C Baiu, Jozsef Karman, Matyas Sandor, Zsuzsanna Fabry.   

Abstract

Dendritic cells (DCs) accumulate in the CNS during inflammatory diseases, but the exact mechanism regulating their traffic into the CNS remains to be defined. We now report that MIP-1alpha increases the transmigration of bone marrow-derived, GFP-labeled DCs across brain microvessel endothelial cell monolayers. Furthermore, occludin, an important element of endothelial tight junctions, is reorganized when DCs migrate across brain capillary endothelial cell monolayers without causing significant changes in the barrier integrity as measured by transendothelial electrical resistance. We show that DCs produce matrix metalloproteinases (MMP) -2 and -9 and GM6001, an MMP inhibitor, decreases both baseline and MIP-1alpha-induced DC transmigration. These observations suggest that DC transmigration across brain endothelial cell monolayers is partly MMP dependent. The migrated DCs express higher levels of CD40, CD80, and CD86 costimulatory molecules and induce T cell proliferation, indicating that the transmigration of DCs across brain endothelial cell monolayers contributes to the maintenance of DC Ag-presenting function. The MMP dependence of DC migration across brain endothelial cell monolayers raises the possibility that MMP blockers may decrease the initiation of T cell recruitment and neuroinflammation in the CNS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17182592      PMCID: PMC1950722          DOI: 10.4049/jimmunol.178.1.520

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  91 in total

1.  Observation of antigen-dependent CD8+ T-cell/ dendritic cell interactions in vivo.

Authors:  B C Schaefer; M L Schaefer; J W Kappler; P Marrack; R M Kedl
Journal:  Cell Immunol       Date:  2001-12-15       Impact factor: 4.868

Review 2.  Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances.

Authors:  Gwendalyn J Randolph; Guzman Sanchez-Schmitz; Veronique Angeli
Journal:  Springer Semin Immunopathol       Date:  2005-01

3.  Cerebrospinal fluid affects phenotype and functions of myeloid dendritic cells.

Authors:  M Pashenkov; M Söderström; Y-M Huang; H Link
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

4.  Experimental autoimmune encephalomyelitis repressed by microglial paralysis.

Authors:  Frank L Heppner; Melanie Greter; Denis Marino; Jeppe Falsig; Gennadij Raivich; Nadine Hövelmeyer; Ari Waisman; Thomas Rülicke; Marco Prinz; Josef Priller; Burkhard Becher; Adriano Aguzzi
Journal:  Nat Med       Date:  2005-01-23       Impact factor: 53.440

Review 5.  Developing DNA vaccines that call to dendritic cells.

Authors:  Michele A Kutzler; David B Weiner
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

6.  Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.

Authors:  Shawn M Sumida; Paul F McKay; Diana M Truitt; Michael G Kishko; Janelle C Arthur; Michael S Seaman; Shawn S Jackson; Darci A Gorgone; Michelle A Lifton; Norman L Letvin; Dan H Barouch
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

7.  Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.

Authors:  Tuula O Jalonen; Kati Pulkkinen; Maritta Ukkonen; Marika Saarela; Irina Elovaara
Journal:  J Neurol       Date:  2002-05       Impact factor: 4.849

8.  Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis.

Authors:  Mathilde Kouwenhoven; Volkan Ozenci; Annelie Tjernlund; Mikhail Pashenkov; Mohammed Homman; Rayomand Press; Hans Link
Journal:  J Neuroimmunol       Date:  2002-05       Impact factor: 3.478

9.  Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin.

Authors:  Gudrun Ratzinger; Patrizia Stoitzner; Susanne Ebner; Manfred B Lutz; Guy T Layton; Christian Rainer; Robert M Senior; J Michael Shipley; Peter Fritsch; Gerold Schuler; Nikolaus Romani
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

10.  Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes.

Authors:  Chunfeng Qu; Emmerson W Edwards; Frank Tacke; Véronique Angeli; Jaime Llodrá; Guzman Sanchez-Schmitz; Alexandre Garin; Nasreen S Haque; Wendy Peters; Nico van Rooijen; Carmen Sanchez-Torres; Jonathan Bromberg; Israel F Charo; Steffen Jung; Sergio A Lira; Gwendalyn J Randolph
Journal:  J Exp Med       Date:  2004-11-08       Impact factor: 14.307

View more
  58 in total

Review 1.  Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS.

Authors:  Benjamin D Clarkson; Erika Héninger; Melissa G Harris; JangEun Lee; Matyas Sandor; Zsuzsanna Fabry
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 2.  Trafficking of immune cells in the central nervous system.

Authors:  Emma H Wilson; Wolfgang Weninger; Christopher A Hunter
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

Review 3.  Matrix metalloproteinases as modulators of inflammation.

Authors:  Anne M Manicone; John K McGuire
Journal:  Semin Cell Dev Biol       Date:  2007-07-10       Impact factor: 7.727

Review 4.  Sensing the microenvironment of the central nervous system: immune cells in the central nervous system and their pharmacological manipulation.

Authors:  Zsuzsanna Fabry; Heidi A Schreiber; Melissa G Harris; Matyas Sandor
Journal:  Curr Opin Pharmacol       Date:  2008-09-02       Impact factor: 5.547

Review 5.  Mechanisms of dendritic cell trafficking across the blood-brain barrier.

Authors:  Divya Sagar; Catherine Foss; Rasha El Baz; Martin G Pomper; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-06       Impact factor: 4.147

6.  Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.

Authors:  Doina Ganea; Virginia Kocieda; Weimin Kong; Jui-Hung Yen
Journal:  Clin Lipidol       Date:  2011-06

7.  Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infection.

Authors:  Mark D Trottier; Douglas S Lyles; Carol Shoshkes Reiss
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

8.  Screening of biochemical and molecular mechanisms of secondary injury and repair in the brain after experimental blast-induced traumatic brain injury in rats.

Authors:  Patrick M Kochanek; C Edward Dixon; David K Shellington; Samuel S Shin; Hülya Bayır; Edwin K Jackson; Valerian E Kagan; Hong Q Yan; Peter V Swauger; Steven A Parks; David V Ritzel; Richard Bauman; Robert S B Clark; Robert H Garman; Faris Bandak; Geoffrey Ling; Larry W Jenkins
Journal:  J Neurotrauma       Date:  2013-06-05       Impact factor: 5.269

9.  PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities.

Authors:  Wen Huang; Sung Yong Eum; Ibolya E András; Bernhard Hennig; Michal Toborek
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

10.  Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide.

Authors:  Ray Chui; Katerina Dorovini-Zis
Journal:  J Neuroinflammation       Date:  2010-01-04       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.